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Abstract
The circadian clock located in the suprachiasmatic nucleus (SCN) in mammals entrains to ambient light via the
retinal photoreceptors. This allows behavioral rhythms to change in synchrony with seasonal and daily changes
in light period. Circadian rhythmicity is progressively disrupted in Huntington’s disease (HD) and in HD mouse
models such as the transgenic R6/2 line. Although retinal afferent inputs to the SCN are disrupted in R6/2 mice
at late stages, they can respond to changes in light/dark cycles, as seen in jet lag and 23 h/d paradigms. To
investigate photic entrainment and SCN function in R6/2 mice at different stages of disease, we first assessed the
effect on locomotor activity of exposure to a 15 min light pulse given at different times of the day. We then placed the
mice under five non-standard light conditions. These were light cycle regimes (T-cycles) of T21 (10.5 h light/dark), T22
(11 h light/dark), T26 (13 h light/dark), constant light, or constant dark. We found a progressive impairment in photic
synchronization in R6/2 mice when the stimuli required the SCN to lengthen rhythms (phase-delaying light pulse, T26,
or constant light), but normal synchronization to stimuli that required the SCN to shorten rhythms (phase-advancing
light pulse and T22). Despite the behavioral abnormalities, we found that Per1 and c-fos gene expression remained
photo-inducible in SCN of R6/2 mice. Both the endogenous drift of the R6/2 mouse SCN to shorter periods and its
inability to adapt to phase-delaying changes will contribute to the HD circadian dysfunction.
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Introduction
The circadian clock, located in the suprachiasmatic
nucleus (SCN) of the anterior hypothalamus, generates
endogenous rhythms that can be reset by ambient light.
This is to ensure that our internal body functions are
appropriately synchronized and adapted to the light/dark
(LD) cycle of the environment. The process of photic
entrainment is initiated by retinal photoreceptors that re-
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Significance Statement
Circadian dysfunction manifests early in Huntington’s disease (HD). Given the importance of circadian
function to human behavior, such deficits have the potential to exacerbate symptoms of HD, particularly
cognitive impairment and irritability. Here we tested the ability of a mouse model of HD that exhibits
progressive circadian abnormalities (R6/2 line) to adjust their circadian rhythms to environmental cues
(photic synchronization). We found that photic synchronization was impaired when the stimuli required the
suprachiasmatic nucleus (SCN) to lengthen its rhythms, but normal when the SCN was required to shorten
them. Interestingly, light-inducible gene expression still occurred in SCN of R6/2 mice that were behaviorally
unresponsive to a light pulse, suggesting that afferent inputs to the SCN were functional.
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ceive, integrate, and transfer the light information via the
retinohypothalamic tract to the SCN (Perez-Leon et al.,
2006). Circadian timing involves the tight regulation of
clock gene expression in the SCN: the dimerization of the
positive elements CLOCK and BMAL1 promote the ex-
pression of negative elements Period (Per) and Crypto-
chrome (Cry). In turn, PER and CRY inhibit the CLOCK/
BMAL1 complex, closing the feedback transcriptional
loop (for review, see Albrecht, 2006; Ko and Takahashi,
2006). Photic stimulation acutely induces the expression
of Per genes in the SCN (Albrecht et al., 1997; Shearman
et al., 1997; Bae et al., 2001), suggesting their involvement
in light-induced circadian shifts.
Huntington’s disease (HD) is a neurodegenerative dis-
ease caused by a pathologic CAG repeat expansion in the
huntingtin gene. In addition to a complex set of progres-
sive motor, cognitive, and psychiatric symptoms (Bates
et al., 2015; Schobel et al., 2017), HD is characterized by
a progressive disruption in sleep and circadian rhythms
(Aziz et al., 2010; Morton, 2013; van Wamelen et al.,
2015). The circadian disruption is recapitulated in multiple
mouse models of HD (Morton et al., 2005; Kudo et al.,
2011; Lin et al., 2019), including the R6/2 mouse used in
this study. Although the circadian disruption observed in
R6/2 mice is accompanied at a molecular level by a
dysregulation of the clock genes expression in the SCN
(Morton et al., 2005), the molecular machinery in the SCN
remains functionally intact (Pallier et al., 2007). This sug-
gests that the circadian phenotype is due to dysfunctional
circuitry in the R6/2 mice rather than disruption to the
molecular clock. The circadian system can be divided into
the three components (Brown and Schibler, 1999): the
retina and retinal afferents to the SCN that modulate
rhythms so they are adapted to the environment; the
master clock that generates the rhythms; and the effer-
ents from the SCN that allow the rhythmic information to
be spread throughout the body (Cermakian et al., 2001).
The first component of the circadian system to be dis-
rupted in HD may be the retinal dysfunction and degen-
eration that has been described in R6/2 and other HD
mice models (Helmlinger et al., 2002; Petrasch-Parwez
et al., 2004; Batcha et al., 2012; Ragauskas et al., 2014).
A recent study has found deficits in retina function of the
R6/2 mouse that might cause disruption of light transmis-
sion to the SCN (Ouk et al., 2016b). That study reported a
decrease in pupillary light responses (PLRs; or the ability
of the pupil to constrict in response to light, a marker of
light reception in the retina) that is correlated with down-
regulation of the photopigments melanopsin and cone
opsin in both R6/2 mice and a full-length knock-in mouse
model of HD (Ouk et al., 2016b). Behaviorally, however,
the situation is complex. The period length of R6/2 mice
under a 12 h LD cycle is pathologically shortened (to 23
h) as the disease progresses (Wood et al., 2013; Ouk
et al., 2017), which is consistent with a progressive insen-
sitivity to light. Nevertheless, symptomatic R6/2 mice re-
main behaviorally responsive to paradigms involving light
manipulations. Bright-light therapy delays circadian rhythm
disruption (Cuesta et al., 2014), and R6/2 mice can entrain
to a 23 h day and adapt to phase advances in the jet lag
paradigm (Wood et al., 2013). Furthermore, variations of
photoperiod lengths are able to reverse, accelerate, or
delay the circadian disruption (Ouk et al., 2017).
Light is the most powerful cue for resetting the circa-
dian clock in response to photoperiod changes. The
phase response curve (PRC) is a particularly useful exper-
imental tool for investigating the responsiveness of an
organism to acute light (Daan and Pittendrigh, 1976;
Johnson, 1999). In this study, we investigated the mech-
anisms of light entrainment in R6/2 mice using PRCs to
light at different stages of the disease. These were pres-
ymptomatic (9 weeks, when mice do not exhibit any
HD-related phenotype), early symptomatic stage (12
weeks, when mice show mild HD phenotype), and late
symptomatic stage (14 weeks, when mice show severe
phenotype). We subsequently assessed the expression of
the photo-inducible clock gene Per1 and the marker of
neuronal activity c-fos in the SCN of R6/2 mice subjected
to light pulses to investigate the molecular mechanisms of
photic entrainment. Finally, we tested the limitation of
SCN entrainment by placing R6/2 mice under variable
length of T-cycles (21, 22, and 26 h) and under conditions
of constant light (LL) or constant darkness (DD).
Materials and Methods
Animals and housing conditions
All experimental procedures in this study were per-
formed under the Animals (Scientific Procedures) Act
1986 Amendment Regulations 2012 and in accordance
with the ethical review by the University of Cambridge
Animal Welfare and Ethical Review Body.
Wild-type (WT) and R6/2 mice on a CBA  C57BL/6J
background were used. The genotype and determination
of the number of CAG repeats was conducted on tail
snips by Laragen using GeneMapper and verified after
completion of the experiments. In total, 267 R6/2 and 155
WT mice were used in the study. R6/2 mice had a mean
(SEM) CAG repeat of 252  3.
Before the experiments, mice were group-housed in
cages of the same sex and genotype. For the measure-
ment of daily activity patterns, mice were individually
housed in a ventilated, light-tight and sound-proof Scan-
tainer cabinet (Scanbur) with a built-in light system (min-
imum, 100 lux). Humidity was maintained at 55  10%
and temperature at 22  1°C. Mice had ad libitum access
to food and water, which was delivered by lowered bottles
with elongated spouts to facilitate access for symptom-
atic R6/2 mice.
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Four experiments were conducted (for details, see be-
low). For the entrainment to light pulses experiment, a
total of 83 WT and 197 R6/2 mice were used (Table 1,
Light pulse experiment). For in situ hybridization analysis,
12 WT and R6/2 female mice were exposed to a light
pulse for 15 min at the age of 14 weeks and left undis-
turbed for 45 min before being killed. We only used fe-
males for the in situ hybridization experiment because of
mouse availability (R6/2 males were used for breeding).
Since all mice, regardless of sex, responded the same
way to light pulse with appropriate advance or delayed
phase shift for the corresponding CTs, we expected that
the response would be similar in male mice, although we
did not measure it. A small group of three WT and three
R6/2 mice were chosen at random from this larger set of
mice for the in situ hybridization experiment after verifying
that the light pulse was given at the right circadian time
point. For the entrainment to the T-cycles experiment, a
total of 55 WT and 53 R6/2 mice were used (Table 1,
T-cycle experiment). For the free-running rhythms exper-
iment, a total of 17 WT and 17 R6/2 mice were used
(Table 1, Free-running rhythms experiment).
For entrainment to light pulses, mice were used once or
twice and were exposed to a single light pulse [Table 1
shows a summary of the number and sex of animals
tested at each circadian time (CT)]. At 9 weeks, 112 naïve
R6/2 mice were used. At 12 weeks of age, 99 of these
mice and 5 naïve mice were subjected to a second light
pulse. (Of the original 112 mice, 13 were excluded be-
cause of arrhythmicity.) Finally, 80 R6/2 naïve mice were
tested at 14 weeks of age. Eighty-three WT mice were
used in this experiment. All WT mice were subjected to
light pulses at 9 weeks of age, and 30 of those were
subjected to a second light pulse between 14 and 30
weeks of age. Since WT mice do not exhibit any photic
disruption between 9 and 30 weeks, all data from the WT
mice, regardless of the age at which they received the
light pulse, were pooled together for analysis and com-
parison with R6/2 groups. Where mice were tested twice,
the light pulses were given at different CTs, with an inter-
val of at least 4 weeks between the light pulses. Mice were
excluded from the study if their circadian rhythms became
arrhythmic.
Survival
Survival was measured when a mouse was killed for
humane reasons because of their disease, if they became
moribund, or if they failed to rouse after gentle stimulation.
No WT mice were killed due to ill health during the study.
Circadian analysis
Circadian activity data were collected from each mouse
using passive infrared motion sensors (catalog #DS936,
Bosch) placed on top of the cage and connected to a
computer with a recording system (ClockLab, Actimet-
rics). Activity patterns were double plotted in 5 min bins
and periodograms were generated with ClockLab soft-
ware (R2015a, Actimetrics) to analyze circadian parame-
ters of the behavioral rhythms. Period length of circadian
rhythms (, time to complete one cycle) was calculated
with the least-squares regression line fitted to the activity
onsets of the data period to analyze, and verified with the
Table 1: Numbers and sex of mice used in the light pulse, T-cycle, and free-running rhythm experiments
WT mice
R6/2
9 weeks 12 weeks 14 weeks
Males Females Males Females Males Females Males Females
Light pulse experiment
Circadian time
CT0 4 4 7 7 7 8 5 3
CT3 9 6 3 5 6 5 4 3
CT6 7 6 7 6 5 5 5 3
CT9 4 9 5 10 5 7 1 4
CT12 6 8 11 4 6 5 4 8
CT15 4 8 6 4 7 7 4 3
CT18 6 13 8 9 5 6 5 5
CT21 6 4 3 5 3 5 5 5
CT23 6 4 6 6 7 5 5 4
CT24 4 4 7 7 7 8 5 3
WT R6/2
Males Females Males Females
T-cycle experiment
T-cycle
T21 10 9 8 9
T22 9 9 9 9
T26 9 9 9 9
WT R6/2
Males Females Males Females
Free-running rhythms experiment
T-cycle
LL and DD 8 8 9 9
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2 periodograms (level of significance set at p  0.001).
The duration of active period () was determined as the
difference between least-squares regression lines fitted
respectively to the activity onsets and offsets of the data
period to be analyzed. General activity during active and
rest periods was determined using the counts provided by
the profile activity function of the ClockLab software. The
rest/activity ratio was calculated as the amount of activity
occurring during the rest period, as a fraction of the
amount of activity occurring during the total activity.
Phase shifts after a light pulse were calculated automat-
ically after determination of the least-squares fits to the
activity onsets for data of the week before the light pulse
(t1) and the week after the light pulse (t2). The resulting
phase shift was calculated as equal to (t1  t2)  24/.
Lighting conditions
The mice were exposed to different light/dark condi-
tions for each experiment. A diagram illustrating the ex-
perimental design is shown in Figure 1.
Entrainment to light pulses
All mice were singly housed in the circadian cabinet for
7–10 d of habituation under a 12 h LD cycle (lights on at
07:00 A.M. and off at 7:00 P.M.) before the start of the
experiment, followed by at least 10–14 d in total darkness
(DD) to allow endogenous rhythm expression. Activity was
recorded throughout the experimental period. Once the be-
havioral circadian rhythms of mice were “free running,” the
mice received a 15 min light pulse (white light, 300 lux) at
different CTs: 0, 3, 6, 9, 12, 15, 18, 21, or 23. After exposure
to a single light pulse, mice were placed back in the circa-
dian cabinet under DD to record activity for at least 10–14 d
to allow calculation of shifts in activity onsets induced by the
light pulse. Any mice receiving a light pulse that became
arrhythmic during the study were excluded from the analy-
sis, since the phase shift could not be calculated.
Entrainment to T-cycles
Mice were placed at 9 weeks of age in circadian cabi-
nets under a 12 h LD cycle (T24) for 1 week. They were
then placed under a T-cycle with a length of T21 (10.5 h
LD cycle), T22 (11 h LD cycle), or T26 (13 h LD cycle) for
5 weeks between the ages of 10 and 15 weeks. Then, the
mice were placed in DD from 15 weeks of age for the
remainder of the experiment.
Measuring free-running rhythms under constant light or
constant darkness
WT and R6/2 mice were placed in a circadian cabinet
from 6 weeks of age under a 12 h LD cycle. Between 8
and 11 weeks of age, mice were exposed to LL. Between
12 and 14 weeks of age, they were then placed under DD.
Finally, at 15 weeks of age, they were placed again under
LL where they remained until they were 17 weeks of age.
In situ hybridization
Twelve-week-old WT and R6/2 mice were placed in DD
for 10–14 d. On day 15, mice were subjected to a 15 min
light pulse (white light, 300 lux) at CT6, CT15, or CT23 and
placed back in the circadian cabinet in the dark for 45 min.
Mice were subsequently killed by cervical dislocation,
their brains were collected and immediately snap frozen
and stored at 80°C.
Sense and antisense c-fos and vasoactive intestinal
peptide gene (vip) mRNA riboprobes were made by
PCR amplification using primers designed from a Na-
tional Center for Biotechnology Information reference
sequence (NM_010234.2 and NM_001313969.1, re-
spectively) and subcloned into the Invitrogen pCRII-
TOPO vector (Thermo Fisher Scientific). Sense and
antisense Per1 mRNA riboprobes were obtained from a
plasmid received as a gift from Prof. Michihiro Mieda
(Mieda et al., 2015) from the Department of Molecular
Neuroscience and Integrative Physiology, Faculty of
Medicine, Kanazawa University, Japan. An RNA sense
probe for each respective gene, c-fos, Per1, and Vip,
were used as a negative control for the in situ hybrid-
ization.
Brain sections were cut coronally at a thickness of 18
m. Sections were cut in a way that resulted in multiple
Figure 1. Experimental outline and light schedule for testing. The diagram shows the different light/dark settings for the light pulse,
in situ hybridization, T-cycle changes (with T24 corresponding to 12 LD cycle; T21 to 10.5 LD cycle; T22 to 11 LD cycle and T26 to
13 LD cycle) and constant light (LL)/dark (DD) experiments. Black arrowheads and yellow lines show the age at which the 15 min light
pulse was administered.
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sections of the SCN on different slides, and we were
therefore able to repeat the RNA detection in the same
animal and reproduce/confirm the results. Slides were
washed with 1 PBS with 0.1% Tween 20, permeabilized
with proteinase K, followed by acetylation solution (0.05%
acetic anhydride in 0.1 M triethanolamine). For hybridiza-
tion, digoxigenin-labeled probes (1:100) were added to
prewarmed prehybridization mix (50% formamide, 6
SSC, 5 Denhardt’s solution, 0.5% SDS, 100 g/ml
tRNA) at 70°C overnight. To wash the unbound probe,
slides were washed with 5 SSC followed by 0.2 SSC.
The slides were washed with 1 maleic acid buffer con-
taining 0.1% Tween 20. The slides were blocked with
blocking solution (2% Boehringer blocking reagent and
20% goat serum in 1maleic acid buffer containing 0.1%
Tween 20) for 1 h. Alkaline phosphatase-conjugated anti-
digoxigenin antibody (catalog #AB_2734716, Roche) was
added to the blocking solution at 1:2000 and incubated at
4°C overnight. The slides were washed with 1 maleic
acid buffer containing 0.1% Tween 20, followed by alka-
line phosphatase buffer (NTMT: 100 mM NaCl, 100 mM
Tris-HCl, pH9.5, 50 mM MgCl2, 1% Tween 20). The sub-
strate (13 l of nitro blue tetrazolium and 10.5 l of
5-Bromo-4-chloro-3-indolyl phosphate) was added to
NTMT. Once the color had developed to the desired
intensity, which was predetermined and constant for all
slides at 48 h, the slides were washed in 1 PBS.
Images were taken using a Nikon Eclipse 80i microscope
with an MBF Bioscience camera and Stereo Investigator
10.54 software (MBF Bioscience; RRID:SCR_002526) and
have not been analyzed or manipulated further. Since
Per1 and c-fos RNA expressions are induced by light
pulse, we were therefore interested in the qualitative de-
tection of the RNA. As the increase (or not) of RNA
Table 2: Statistical table
Comparison Data structure Type of test Power
a PRC CT18 WT vs
9 week R6/2
Normal distribution Kruskal–Wallis test, post hoc
Dunn’s multiple-comparisons test
p  0.0375
b PRC CT3 WT vs
9 week R6/2
Normal distribution for WT,
N too small for
9-week-old R6/2
Kruskal–Wallis test, post hoc
Dunn’s multiple-comparisons test
p  0.0002
c PRC CT23 WT vs
9 week R6/2
Normal distribution Kruskal–Wallis test, post hoc
Dunn’s multiple-comparisons test
p  0.0068
d PRC CT24 WT vs
9 week R6/2
Normal distribution for
R6/2, not for WT
Kruskal–Wallis test, post hoc
Dunn’s multiple-comparisons test
p  0.0196
e PRC CT15 WT vs
12 week R6/2
Normal distribution Kruskal–Wallis test, post hoc
Dunn’s multiple-comparisons test
p  0.0010
f PRC CT18 WT vs
12 week R6/2
Normal distribution Kruskal–Wallis test, post hoc
Dunn’s multiple-comparisons test
p  0.0097
g PRC CT24 9 vs
12 week R6/2
Normal distribution for
R6/2, not for WT
Kruskal–Wallis test, post hoc
Dunn’s multiple-comparisons test
n.s., p  0.0789
h PRC CT15 12 vs
14 week R6/2
Normal distribution Kruskal–Wallis test, post hoc
Dunn’s multiple-comparisons test
n.s., p  0.5049
i PRC CT18 12 vs
14 week R6/2
Normal distribution Kruskal–Wallis test, post hoc
Dunn’s multiple-comparisons test
n.s., p  0.9999
j, k, l  under
T26 WT & R6/2
Normal distribution for
R6/2, not for WT
Repeated-measures ANOVA,
post hoc Bonferroni test
p  8.38E-8;
p  4E-5;
p  9.15E-10
m  under
T26 WT & R6/2
Normal distribution for
R6/2, not for WT
Repeated-measures ANOVA,
post hoc Bonferroni test
p  2.43E-06
n Survival curves
under T21 vs T22
- Log-rank (Mantel–Cox) test p  0.0035
0 Survival curves under
T21 vs T24
- Log-rank (Mantel–Cox) test p  0.0025
p Survival curves under
T21 vs T26
- Log-rank (Mantel–Cox) test p  0.0050
q, r, s  under constant
light R6/2 vs WT
Normal distribution Repeated-measures ANOVA,
post hoc Bonferroni test
p  0.016;
p  5.42E-10;
p  0.017
t, u  under constant
light R6/2 vs WT
Normal distribution Repeated-measures ANOVA,
post hoc Bonferroni test
p  8.49E-6;
p  2.47E-13
v  under second constant
light R6/2 vs WT
Normal distribution Repeated-measures ANOVA,
post hoc Bonferroni test
p  5.22E-07
w Period length under
DD WT vs R6/2
Normal distribution Repeated-measures ANOVA,
post hoc Bonferroni test
p  3E-4
x Amplitude of rhythms under
DD WT vs R6/2
Normal distribution Repeated-measures ANOVA,
post hoc Bonferroni test
p  0.0006
y Activity counts under
DD WT vs R6/2
Normal distribution for
R6/2, not for WT
Repeated-measures ANOVA,
post hoc Bonferroni test
p  6E-5
The letter for each line of the table refer to the numerical values provided in the text as they appear in the Results.
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expression after light pulse was obvious in the images, we
did not attempt to quantify the expression levels.
Statistics
All data are expressed as the mean  SEM. Statistical
differences were analyzed using StatSoft Statistica 19.0
software (version 12, StatSoft) or Prism (version 7.00,
GraphPad Software). When applicable, normality distribu-
tion was tested with the D’Agostino and Pearson normal-
ity test. All data were initially analyzed for each sex
separately. However, the goal of our experiments was not
to study sex dimorphism, but to study the effect of HD
mutation in disrupting photic synchronization. For the light
pulse experiment, phase shifts in response to the light
pulse were in the same direction for both sexes (i.e., both
either increased or decreased depending on the time of
the light pulse), and no sex differences were found. There-
fore, for each experiment (light pulses, T-cycle, and LL or
DD), data from both sexes were pooled for clarity of
presentation. For the light pulse experiment, differences
between groups were analyzed with a Kruskal–Wallis test
followed by a Dunn’s multiple-comparisons test. For the
T-cycles, LL, and DD experiments, differences between
groups were analyzed using an ANOVA with repeated
measures, followed by Bonferroni post hoc test. The level
of significance was set at p  0.05. All statistical tests are
presented in Table 2.
Results
Progressive alteration in response to light pulse in
R6/2 mice
After exposing mice to a light pulse at various CTs
throughout a 24 h period, we obtained a PRC. The PRC to
light of WT mice with a CBAC57BL/6 background (Fig.
2A) exhibited the same characteristics of the PRC ob-
tained from pure C57BL/6 mice reported previously in the
literature (Pendergast et al., 2010). Three clearly identifi-
able regions of the curve were observed, namely a “dead”
region during most of the subjective day (CT3–CT9),
where the light pulse did not induce any shift in the activity
onset on subsequent days; a “phase delay” region during
the early subjective night (CT9–CT18) that caused a
phase delay of 3.2 h at CT15; and a “phase advance”
region during late subjective night (CT21–CT24) that
caused a phase advance of 1 h at CT24 (Figs. 2A,
3A–C).
The shape of the PRC to light pulse obtained in R6/2
mice at 9 weeks of age (Fig. 2B) resembled that of WT
mice, with a dead region (no response), a phase delay
region, and a phase advance region. However, the mag-
nitude of the shifts was different (Figs. 2B, 3D–F), with
significantly smaller shifts in R6/2 mice in the delay region
at CT18 (p  0.04)a, and significantly larger shifts at CT3
(p  0.001)b and in the advance region at CT23 (p 
0.007)c and CT24 (p  0.02)d. With increasing age and
consequently disease progression, the PRC progressively
flattened. By 12 weeks of age, the phase shifts were
significantly smaller only in the delay region at CT15 (p 
0.001; Figs. 2C, 3H)e and CT18 (p  0.01; Fig. 2C)f, and
Figure 2. Phase responses to a single light pulse in WT and R6/2
mice. A–D, Graphs show phase response curves in response to
a 15 min light pulse at 300 lux for WT mice (open symbols in A–D)
and R6/2 mice (solid symbols) at presymptomatic (B; 9 weeks of
age), early symptomatic (C; 12 weeks of age) and symptomatic
(D; 14 weeks of age) time periods. Data for CTs are double
plotted at CT0 and CT24 for clarity of presentation. The WT curve
from A is replicated in B–D (dashed line) for easy comparison
with the R6/2 data (solid lines). Vertical black dash lines indicate
the boundaries of the dead zone, delay zone, and advance zone.
All data are shown as the mean  SEM with a minimum of n 
3 at each time point (p  0.05; p  0.01).
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the differences seen at 9 weeks of age in the advance
region were abolished (Figs. 2C, 3I)g. At 14 weeks of age,
R6/2 mice subjected to light pulses were still rhythmic
(Fig. 3J–L), but the resulting phase shifts at CT15h and
CT18i were no longer existent (Figs. 2D, 3K).
The shape of the WT PRC was asymmetrical, with the
delay region larger than the advance region (Fig. 4). The
PRCs from R6/2 mice were also asymmetrical regardless
of the age, but this time the delay region was smaller than
the advance region.
Normal expression of Per1 and c-fos is induced in
the SCN of R6/2 mice after a light pulse
To establish whether the progressive changes in PRC
of R6/2 mice were related to the disruption of light-
inducible gene expression in the SCN, we conducted in
Figure 3. Shifts in activity onset induced by light pulses in R6/2 and WT mice. A–L, Representative single-plotted actograms of WT
mice (A–C) and R6/2 mice at the age of 9 weeks (D–F), 12 weeks (G–I), and 14 weeks (J–L) placed under constant darkness and
subjected to a single 15 min light pulse (300 lux) at CT6, CT15, or CT23. The arrow at the right of each actogram indicates the day
when the light pulse was administered. The blue lines indicate the activity onset for 7 d before the light pulse, and the red lines indicate
the activity onsets for the 7 d following the light pulse.
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situ hybridization to analyze the expression of Per1 and
c-fos after a light pulse in three WT and three R6/2 mice
at 14 weeks of age. The SCNs of all three mice tested
showed the same expression patterns before and after a
light pulse for c-fos, Per1, and Vip for all the circadian
times tested regardless of genotype.
Results obtained were similar at all the ages tested
(data not shown). Consistent with the literature with nor-
mal mice placed under 12 h LD cycle (Shearman et al.,
1997, Bae et al., 2001), we found Per1 expression in
control conditions (DD, no light pulse) was high during the
rest period at CT6 and low during the active period at
CT15 and CT23 in both WT and R6/2 SCN (14-week-old
mice are shown in Fig. 5A). Per1 expression was upregu-
lated after a light pulse in both WT and R6/2 mice during
the subjective night at CT15 and CT23 (Fig. 5A). In WT
and R6/2 mice, c-fos expression in basal conditions in
DD was low for all CTs, and was induced after a light
pulse given during the subjective night at CT15 and
CT23, but not during the subjective day at CT6 (Fig.
5B). This was consistent with the literature for WT mice
placed under a 12 h LD cycle (Colwell and Foster,
1992). The levels of expression of Vip, an SCN neuro-
peptide output involved in rhythmicity, were also similar
in WT and R6/2 mice, both in basal conditions and after
a light pulse (Fig. 5C).
Normal entrainment to short days of 22 h, but
abnormal entrainment to long days of 26 h
To confirm the disrupted circadian phenotype seen with
the PRCs (e.g., an altered delayed phase shift in symp-
tomatic R6/2 mice), we investigated the stability range of
entrainment of R6/2 mice by analyzing their entrainment
to short or long LD T-cycles. Under the T21 cycle, the WT
and R6/2 mice did not entrain (Fig. 6A,B). Only 1 of 19 WT
mice synchronized to T21. Both WT and R6/2 mice ex-
hibited significant negative masking (light-mediated sup-
pression of locomotor activity in rest phase; Mrosovsky,
1999). All mice showed clear endogenous rhythms for the
5 weeks they were under the T21 cycle, albeit with mean
period lengths21 h (WT mice, 22.8 0.02 h; R6/2 mice,
22.8  0.02 h; Fig. 6C). Under T22, both WT and R6/2
mice entrained to the LD cycle (Fig. 6D,E), and the mean
period length for the 5 weeks under the T22 cycle was not
significantly different between genotypes (WT mice, 22.2
 0.02 h; R6/2 mice, 22.5  0.01 h; Fig. 6F). The entrain-
ment of R6/2 mice to T22 was, however, not the same as
that of the WT mice, which started their locomotor activity
exactly at the time of lights off. Rather, R6/2 mice sus-
tained a 22 h rhythm for a few weeks of the T22 applica-
tion, with a start of their active period that was shifted in
the light period. The 22 h rhythm was then disrupted with
further shifting of the active period in the light period,
leading progressively to rhythm disintegration. Under T26,
WT mice entrained to the T-cycle for the whole of the
experimental period (Fig. 6G). R6/2 mice, however, en-
trained to T26 only during the first 2 weeks (Fig. 6H). After
that, they were unable to sustain the long rhythm and their
period length gradually shortened (Fig. 6H,I). There was a
main effect of both genotype (F(1,34) 46.04; p 8,38E-8
j)
and age (F(4,136)  7.00; p  4E-5
k) on period length, as
well as interactions between these two factors (F(4,136) 
14.29; p  9.15E-10l).
There were no significant differences in the duration of
the active period betweenWT and R6/2 mice under T21 or
T22 (Figs. 7A,C), but there was a main effect of genotype
under T26 (F(1,34)  31.96; p  0.001
m; Fig. 7E), with a
significant increase in the duration of the active period in
R6/2 mice compared with WT mice.
The endogenous period following exposure to T26 (Fig.
6I), was significantly shorter in all R6/2 mice placed in DD
compared with WT mice, but only at the last time point
tested for T21 (Fig. 6C) and T22 (Fig. 6F). In R6/2 mice,
significant increases in  were observed only under T26
and activity counts were significantly decreased only un-
der T22 and T26 compared with WT mice (Fig. 7).
Finally, we found that subjecting the R6/2 mice to T21
was deleterious to their life span (median survival time,
18.7 weeks), which was significantly decreased, com-
pared with R6/2 mice exposed to T22 (median survival
time, 19.8 weeks; p 0.0035n), T24 (median survival time,
20.8 weeks; p  0.0025°), and T26 (median survival time,
20.6 weeks; p  0.005p; Fig. 8). There was no difference
in survival between R6/2 and WT mice exposed to T22,
T24, and T26 cycles.
Entrainment to constant light and constant darkness
in R6/2 mice
To investigate the propensity of the circadian clock in
R6/2 mice to accelerate or decelerate rhythms, and to
determine whether or not time cues masked a circadian
phenotype, we subjected mice to constant conditions (LL
cycles interspaced with DD) and measured the free-
running circadian periods of the SCN (Fig. 9A,B). In WT
mice, the period length of the free-running rhythms differs
slightly from 24 h, with periods typically 24 h under LL
and 24 h under DD (Aschoff, 1960). During the first
exposure to LL at the presymptomatic stage, R6/2 mice
initially responded in a manner similar to WT mice, with an
increased period length. However, R6/2 mice were unable
to sustain this increase in period length. By 11 weeks of
age, there was a main effect on period length of both
Figure 4. The advance/delay ratio of the phase response curves
is altered in R6/2 mice. Graphs show the change of peak area of
the phase response curve in response to a 15 min light pulse at
300 lux for R6/2 mice at 9, 12, and 14 weeks of age and for WT
mice. The value of the advance/delay ratio is shown above the
bars on the graph.
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genotype (F(1,31)  6.4; p  0.016
q) and time (F(3,93) 
19.8; p  5.42E-10r), with period length significantly
shorter in R6/2 mice than WT mice (p  0.017s; Fig. 9C).
The duration of the active period in R6/2 mice was similar
to that in WT mice (Fig. 9D), but there was a main effect of
age on both activity (F(3,96)  10; p  8.49E-6
t; Fig. 9E)
and amplitude of rhythms (F(3,96)  28.70; p  2.47E-13
u;
Fig. 9F). When we re-exposed the mice to LL at an older
age (between 15 and 17 weeks), the R6/2 mice period
length remained shorter than 24 h (23.12  0.17 h at 17
weeks) compared with WT mice that increased (24.91 
0.18 h; p  5,22E-07v). We found a main effect of geno-
type on period length, activity levels, and amplitude of
rhythms, all of which decreased significantly in R6/2 mice
compared with WT mice (Fig. 9C,E,F).
As seen previously under DD, with age R6/2 mice
exhibited a progressively shorter period length than
was seen in WT mice (Wood et al., 2013; Ouk et al.,
2017). In mice under DD at 12–13 weeks of age, there
was a main effect of genotype on period length (F(1,32) 
16.2; p  3E-4w), amplitude of rhythms (F(1,32)  14.41;
p  0,0006x), and activity counts (F(1,32)  21.43; p 
6E-5y), with all these parameters significantly de-
creased in R6/2 mice compared with WT mice (Fig.
9C,E,F).
Discussion
We show that R6/2 mice are unable to entrain ade-
quately to experimental environmental light changes from
11 weeks of age (presymptomatic stage), and that it is
Figure 5. Expression of Per1 and c-fos in the SCN induced by a single light pulse in WT and R6/2 mice. A–C, Representative
photomicrographs show mRNA expression in the SCN by in situ hybridization of Per1 (A), c-fos (B), and Vip (C) in 14-week-old R6/2
and WT mice under DD or 45 min after a light pulse (15 min, 300 lux minimum) at CT6, CT15, or CT23. The SCN, medial preoptic
nucleus (MPN), and anterior hypothalamic nucleus (AHN) are indicated with dashed outlines. Scale bar, 200 m.
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more problematic when a deceleration of the period of
their circadian rhythms is required than it is when the
period requires accelerating. R6/2 mice could neither
generate phase delays (when housed under DD and sub-
jected to light pulses), nor adapt and maintain their
rhythms to long T-cycles (13 h LD cycle). However, the
R6/2 mice were able to accelerate their rhythms, as they
could both generate phase advances to a light pulse and
adapt to a 22 h T-cycle. The differences we see with WT
mice cannot be attributed to aging per se (since the mice
are still young) but rather to a possible effect of the HD
mutation on aging.
The SCN synchronizes to the LD of the environment
through the action of light received by the light-sensitive
retinal ganglion cells (Panda et al., 2002; Ruby et al.,
2002). Both R6/2 and Q175 mice—a HD model with
slower phenotype development—exhibit progressive ret-
inal morphologic changes, including a downregulation in
the expression of melanopsin and cone opsin, markers of
retinal light-sensitive and cone cells, respectively (Ouk
et al., 2016b; Lin et al., 2019). Photodetection appeared to
be progressively impaired in R6/2 mice because they
exhibited attenuation in their PLR from 12 weeks of age
for light at low intensity. Their PLR was disrupted by bright
light intensity only at a late stage of disease, suggesting
that up to that age light photoreception was still func-
tional, provided the light intensity was sufficiently high. It
has been suggested that the photic entrainment requires
the integration by the circadian timing system of both the
intensity and the duration of photic information (Nelson
and Takahashi, 1991; Kornhauser et al., 1996; Morin and
Allen, 2006). Therefore, our results support the evidence
that there is dysfunction in the retinal inputs to the SCN
that means the SCN is unable to reset to the LD cycle of
the environment if the light is too dim. This would have
consequences in HD patients living in normal lighting
levels, since they may exhibit circadian dysfunction.
Bright-light therapy may be beneficial in HD mice simply
because the light is of sufficient intensity (Cuesta et al.,
2014).
Figure 6. Rest–activity patterns of WT and R6/2 mice under T-cycles of 21, 22, and 26 h. A, B, D, E, G, H, Rest–activity profiles of
WT mice (A, D, G) and R6/2 mice (B, E, H) placed under T24 then T21 (A, B), T22 (D, E), or T26 (G, H), and, finally, constant darkness.
C, F, I, Graphs show the evolution of period length during the changes in light schedules. p  0.05; p  0.01; p  0.001. C,
F, I, The blue dotted line shows the time period of the light settings, or where the light had been set previously for the part of the plot
where the mice were in DD.
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Figure 7. Circadian parameters analyzed in R6/2 and WT mice placed under different T-cycle lengths. A–F, Duration of the active
period (A, C, E) and total activity counts (B, D, F) were analyzed throughout the experiments when WT mice (black histograms) and
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Two types of models have been characterized to inter-
pret the entrainment of the circadian timing system to the
environmental LD cycle (Pittendrigh and Daan, 1976), as
follows: the nonparametric (discrete) and the parametric
(continuous) models. The parametric model suggests that
the circadian clock continuously adjusts to the light inten-
sity by decelerating and accelerating its rhythms to en-
train to the LD cycle. The nonparametric model suggests
that discrete light at specific times of day induce entrain-
ment of the circadian clock with phase shifts equal in
magnitude to the difference between the period of the
rhythm and the period of the LD cycle (Decoursey, 1960;
Pittendrigh, 1960). We tested the nonparametric model
with the PRC to light and revealed early phenotypes in
R6/2 mice whereby they exhibited larger phase advance
but smaller phase delay shifts to light pulses than were
seen in WT mice. This suggests that the SCN in R6/2 mice
is able to accelerate the endogenous rhythms more effi-
ciently but to decelerate them less efficiently than the WT
mice. This early phenotype for phase-advanced shifts had
almost disappeared by the time the R6/2 mice were
tested at 12 and 14 weeks of age, coinciding with the start
of a decline in the health of the mice while the phenotype
for phase-delayed shifts worsened. Given that symptom-
atic R6/2 mice develop a dysregulation in Per2 circadian
expression (Morton et al., 2005), our results are consistent
with an earlier study that demonstrated that Per1/ and
Per2/ mice had larger phase advances than WT mice
(Pendergast et al., 2010). Although we did not measure
Per gene expression at 9 weeks in the R6/2 250CAG
mice, in which the phase advances are larger than those
seen in WT mice, we speculate that an early dysregulation
in the mRNA expression and protein levels of Per 1 and/or
Per 2 might be seen at this age.
By 14 weeks, while all the R6/2 mice tested exhibited
behavioral rhythmicity, their behavioral responses to a
light pulse were almost abolished in the phase delay
section of the curve compared with WT mice. Therefore, it
seems that the deficiency in the circadian timing system in
R6/2 mice is more pronounced at specific circadian
phases, with the R6/2 SCN specifically unable to “reset”
in response to a light cue administered in the early night.
Using short or long T-cycles, but also constant condi-
tions, we were able to confirm the circadian clock pro-
pensity of the R6/2 mice to accelerate rather than
decelerate its rhythms.
The period length of R6/2 mice shortens pathologically
under both DD and LL. This is also the case under a 12 h
LD cycle, when the period length shortens to23 h as the
disease progresses (Wood et al., 2013; Ouk et al., 2017).
It is, therefore, not surprising that R6/2 mice can entrain
more easily to T22 than to T26 since T22 is closer to their
endogenous rhythms and required slowing down the mo-
lecular machinery of the SCN. Entraining to T26 would
require them to adjust by decelerating their endogenous
circadian rhythms by3 h each day. Neither WT nor R6/2
mice entrained to T21, suggesting that this exceeded the
range of entrainment of their SCN. Interestingly, T21 had
a deleterious effect on the survival of R6/2 mice compared
with T22, T24, or T26. The cause of this negative impact
on the health of R6/2 mice is unknown.
R6/2 mice are arrhythmic at 16 weeks of age, when the
behavioral circadian disruption is accompanied by a dis-
ruption in clock gene expression (Per2, Bmal1) in the SCN
(Morton et al., 2005; Pallier et al., 2007; Maywood et al.,
2010). The molecular clock in the SCN from 16-week-old
R6/2 mice is, however, able to function normally in vitro
(Morton et al., 2005; Pallier et al., 2007; Williams et al.,
2011). Per1 in particular has been shown to be important
for photic entrainment in the mammalian circadian system
(Pendergast et al., 2010) with Per1 expression being di-
rectly induced by phase-resetting light pulses (Kuhlman
et al., 2003; Schwartz et al., 2011). c-fos expression in the
SCN is also induced by light (Masana et al., 1996). In
hamsters, c-fos expression was light induced only at
phases where phase resetting occurred (Kornhauser
et al., 1996). We found that the expression of Per1 and
c-fos were light inducible at CT15 and CT23 in 9- and
12-week-old mice that exhibited phase shifts following a
light pulse. We found that the SCN of 14-week-old R6/2
mice, which is still rhythmic but does not generate phase
delays, is still able to respond with clock gene expression
at CT15 and CT23. The disappearance of the behavioral
shifts might be explained by a change in the localization of
Per1 expression in the SCN, since an interesting study
suggested that the spreading of light-induced Per gene
expression from the core to the shell of the SCN is nec-
essary for a behavioral phase shift to be produced, with
Per1 expression in the shell associated with phase ad-
vances, and Per2 with phase delays (Yan and Silver,
2002). Our in situ hybridization results from symptomatic
continued
R6/2 mice (white histograms) were placed under T24 at 9 weeks of age and then under either T21 (A, B), T22 (C, D), or T26 (E, F) for
5 weeks, and, finally, under constant darkness for 5 weeks to analyze after-effects.
Figure 8. Survival of R6/2 mice exposed to different period
lengths. Kaplan–Meier survival curves are shown for R6/2 mice
placed under T24 (black symbols), T21 (red symbols), T22 (green
symbols), and T26 (blue symbols). Survival was significantly
different between mice placed under T21 compared with each of
the other T-cycles tested (Log-rank Mantel–Cox test, p  0.01).
No significant difference in survival was seen among T22, T24,
and T26. p  0.01.
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R6/2 (Fig. 5A) mice show a Per1 expression essentially
confined to the core of the SCN. We did not perform in
situ hybridization in 9-week-old R6/2 mice, and examining
the timing of gene expression in the core/shell of the SCN
was beyond the scope of this study. It would, however, be
interesting to see whether there is a Per1 light-induced expres-
sion in the shell of the SCN at CT21, since that would be
consistent with the phase advance we see at that age.
While our Per1 light-induced expression data support
previous findings that the molecular machinery of the
SCN is intact, they also indicate that retinal dysfunction is
unlikely to be the sole cause of dysrhythmia in R6/2 mice.
In support of this suggestion, previous studies have
shown that R6/2 mice respond to bright light (Cuesta
et al., 2014), jet lag (Wood et al., 2013), and photoperiod
length variation (Ouk et al., 2017). This raises the possi-
bility that the involvement of downstream areas of the
brain innervated by the SCN causes the disruption of the
behavioral response to the phase-delaying light pulse.
Unlike the circadian afferents to SCN, circadian efferents
from the SCN are not well documented, although several
signaling factors in the SCN have been identified as being
involved in the circadian regulation of locomotor activity
(Li et al., 2012). These include vasopressin, prokineticin 2,
TGF (transforming growth factor ), and cardiotrophin-
like cytokine, which are all able to inhibit locomotor activ-
ity when they are infused in the third ventricle of mice
during the night period. There is currently no evidence for
which brain areas are involved in R6/2 mice, but we
speculate that candidate regions could include the inter-
geniculate leaflet, which plays a role in photic entrainment
and receives input from both the retina and SCN (Edel-
Figure 9. Rest–activity patterns of R6/2 mice under light cycle changes among T24, constant light, and constant darkness. A, B, Rest
activity profiles are shown for representative WT mice (A) and R6/2 mice (B) placed under a succession of light conditions, as follows:
a 12 h LD cycle from 6 to 7 weeks of age, LL from 8 to 11 weeks of age, DD from 12 to 14 weeks of age, and, finally, back to LL from
15 to 17 weeks of age. C–F, Histograms show the changes in period length (C), the duration of the active period (D), general activity
(E), and the amplitude of the rhythms (F) according to the light conditions for WT mice (open columns) and R6/2 mice (filled columns).
An asterisk indicates a main effect of genotype: p 0.05; p 0.01; p 0.001. There was no main effect of time. The bar above
the histograms indicates the light condition under which the mice were placed.
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stein and Amir, 1999). Hypothalamic regions are also
good candidates as alterations have been reported both
in HD patients and animal models (Vercruysse et al., 2018;
Cheong et al., 2019). The dorsomedial hypothalamic nu-
cleus is responsible for relaying circadian temporal infor-
mation from the SCN to the locus ceruleus (Gompf and
Aston-Jones, 2008), and excitotoxic lesion of this region
has been reported to decrease behavioral circadian
rhythms including locomotor activity (Chou et al., 2003).
The orexinergic neurons in the lateral hypothalamic area
that promote arousal are particularly of interest in R6/2
mice as their population is reduced and their circadian
activity is disrupted (Williams et al., 2011).
A disruption in the methamphetamine-sensitive circa-
dian oscillator (MASCO), which relies primarily on the
dopaminergic system (Blum et al., 2014), has been re-
ported in HD mice (Cuesta et al., 2012; Ouk et al., 2016a).
Since the MASCO is characterized by increases in period
length, a MASCO deficit in the R6/2 mice might also
underlie their inability to respond to changes in photope-
riod that require lengthening their endogenous period.
Although some studies reported retinal alterations in
HD patients (Paulus et al., 1993; Kersten et al., 2015), to
our knowledge, none investigated a circadian behavior in
parallel. Bright-light therapy has been shown to be effi-
cient in delaying circadian disruption in R6/2 mice by
improving day–night rhythms (Cuesta et al., 2014), even
more so when it is coupled with restricted periods of
voluntary exercise. Circadian disruption has already been
associated with sleep disruption and reduced cognitive
performance but also with disease states such as cancer,
metabolic diseases, and neurocognitive and mood disor-
ders (Sahar and Sassone-Corsi, 2009; Kyriacou and Hast-
ings, 2010; Lyall et al., 2018). In HD patients, circadian
desynchronization has been reported to worsen clinical
symptoms such as irritability, depression, and cognitive
impairment (Aziz et al., 2010; Diago et al., 2018).
Given that the current treatment for HD is limited to a
pharmacological treatment for chorea, research on the
efficacy of bright-light therapies in HD patients to improve
disease management and quality of life is warranted,
particularly since bright-light therapy has positive effects
on mood and sleep in patients with Parkinson’s disease
and Alzheimer’s disease (Dowling et al., 2007; Willis and
Turner, 2007). This alternative and noninvasive approach
therapy has considerable potential to help reduce the
socioeconomic burden of such disease on our society.
In conclusion, we show that R6/2 mice exhibited spe-
cific behavioral impairment in response to phase-delaying
paradigms such as photic stimuli during early night and
entrainment to a 26 h T-cycle, while exhibiting apparently
normal behavior in response to phase-advancing para-
digms such as photic stimuli during early night and en-
trainment to a 22 h T-cycle. Our results show that
although progressive retinal abnormalities are seen in
R6/2 mice, they are able to respond appropriately to light,
provided that it was given at an appropriate phase of the
circadian timing system and that the intensity and dura-
tion of the photic information were sufficient. If photic
entrainment abnormalities are part of the circadian abnor-
malities exhibited by HD patients, then bright-light thera-
pies administered at strategically determined times of day
carry a potential for improving circadian dysfunction and
related comorbidities in such patients.
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